IAMGOLD Corp (NYSE:IAG) Director William Pugliese sold 100,000 shares of the stock on the open market in a transaction dated Tuesday, January 13th. The stock was sold at an average price of C$3.70, for a total transaction of C$370,280.00. On Thursday shares of IAMGOLD Corp. (NYSE:IAG) closed at $3.01. Company’s sales growth for last 5 years was 5.70% and EPS growth for next 5 years is recorded as 3.00%.
Gastar Exploration Inc. (NYSEMKT:GST) on Jan. 5 announced that it has declared monthly cash dividends on its 8.625% Series A Preferred Stock (“Series A Preferred Stock”) and its 10.75% Series B Preferred Stock (“Series B Preferred Stock”) for January 2015. Gastar Exploration Inc. (NYSEMKT:GST) in last trading activity increased 3.32% to close at $2.18. Company weekly performance is 6.34% while its quarterly performance stands at -40.76%. Gastar Exploration Inc. (NYSEMKT:GST) is -76.04% away from its 52 week high.
Mark Rachesky’s $7 billion deal to sell satellite company Loral Space & Communications, Inc. (NASDAQ:LORL) has been grounded, The Post has learned. Talks between Loral and the Ontario Teachers’ Pension Plan, which were active in the fall, have ended, two sources close to the situation said. On last trading day Loral Space & Communications, Inc. (NASDAQ:LORL) decreased -2.27% to close at $74.17. Its volatility for the week is 3.11% while volatility for the month is 2.12%. LORL’s EPS growth for past 5 years was 15.10%. Loral Space & Communications, Inc. (NASDAQ:LORL) monthly performance is -6.49%.
A Cigna Corp. (NYSE:CI) executive said the company expects price competition to address the cost of the drugs, which has become a source of consternation for health insurers. Harvoni, approved by the FDA on Oct. 10, costs $94,500 for a 12-week regimen. Viekira Pak costs $83,320 for 12 weeks of treatment. Cigna is currently negotiating with Gilead and AbbVie. “We are seeing real competition between the two manufacturers which will benefit our customers and clients,” said Christopher Bradbury, vice president of integrated clinical and specialty drug solutions for Cigna Pharmacy Management. Cigna Corp. (NYSE:CI) has 0.20% insider ownership while its institutional ownership stands at 89.90%. In last trading activity company’s stock closed at $106.86.
Ellomay Capital Ltd. (NYSEMKT:ELLO), an emerging operator in the renewable energy and energy infrastructure sector, Wednesday, 31 December 2014 said third-quarter net income was $5.39 million or $0.50 per share, and revenues were about $5.2 million. The company recognized impairment charges of around $0.6 million in connection with a new legislation. Excluding a gain on bargain purchase, depreciation and financing expenses, adjusted EBITDA was $5.12 million. On last trading day Ellomay Capital Ltd. (NYSEMKT:ELLO) decreased -2.66% to close at $9.00. Its volatility for the week is 2.57% while volatility for the month is 2.33%. ELLO’s sales growth for past 5 years was 2.70% and its EPS growth for past 5 years was -37.80%. Ellomay Capital Ltd. (NYSEMKT:ELLO) monthly performance is -7.69%.